Editor's Picks

News to Use

IU trustees to select IUSM-Evansville site; White to lead molecular and gene therapy, and more

Mar. 27, 2014

IU trustees to select IUSM-Evansville site 

IUSM Evansville

A decision on the new site of a multi-institutional academic health science education campus in Evansville is expected to arrive Friday, April 11, during the IU trustees meeting in IU Bloomington.

The four final proposals will be discussed in the early morning in a committee meeting and presented for a vote in the afternoon session beginning at noon.

IU trustees meetings are open to the public. A community event where the general public may view via live-stream broadcast from the meeting is scheduled from 11:30 p.m. to 1 p.m. CDT on April 11 at the Old National Bank Atrium in Evansville. The live feed is expected to begin at 11:45 a.m.

Planning for the expanded medical education campus, which will include space for the IU School of Medicine-Evansville, began in 2012. The campus will also include graduate medical education programs from the University of Evansville, University of Southern Indiana and IU School of Dentistry. Ivy Tech Community College of Southwest Indiana plans to relocate all existing and planned health science programs to the new campus.

A brief presentation and reception with light refreshments will follow the public viewing in Evansville. Seating is limited.

Construction on the new campus is expected to begin in 2015, with classes starting in the fall of 2017.

White to lead molecular and gene therapy

Kenneth White

Kenneth White, Ph.D.

Kenneth White, Ph.D., has been named director of the Molecular and Gene Therapy Division in the Department of Medical and Molecular Genetics. 

Dr. White, who joined IU in 2003, is an associate professor of medical and molecular genetics and David D. Weaver Investigator of Medical and Molecular Genetics at the IU School of Medicine. He is an internationally recognized expert in the field of endocrine control of mineral metabolism, which centers on phosphate and vitamin D metabolism in renal and bone function and two NIH R01 research grants, including “FGF23 Regulation of Phosphate Homeostasis,” which has twice renewed, as well as a second recently funded grant focused on understanding the novel role of the FGF23 co-receptor Klotho in a new endocrine feedback loop.

His work has been described as "exemplifying the way in which key studies in basic science can enhance our understanding of clinical disorders and serves as the basis for translational research." As an educator, Dr. White is also known as a dedicated lab mentor whose former trainees hold competitive faculty positions in the U.S. and abroad.

Dr. White's service to IU includes status as a permanent membership on the IU Internal Review Board 4, a member of the IUSM Faculty Steering Committee, a representative on the IUPUI Faculty Council and a participant in the IUSM Awards Committee. He is also the recipient of numerous national and international honors, including one of the inaugural recipients of the IU Showalter Scholar Award.

IUSM Dean Jay Hess TRIP Keynote video

IUSM Dean and IU Vice President for University Clinical Affairs Jay Hess, M.D., Ph.D., one of the nation's leaders in epigenetics of leukemia, presented 2014 IUPUI Translating Research Into Practice Keynote lecture on March 13.

In his address, "Speeding the Clinical Translation of Discovery," Dr. Hess shared some of his experiences in early-stage drug discovery in academia and in establishing sequencing-based diagnostics to improve care for cancer patients.

As the genetic abnormalities that underlie cancer are being defined, new opportunities arise to develop more targeted and effective therapies; however, bottlenecks remain in clinical translation.

A video of the address is available on the IUSM Communications YouTube channel.

KC IRB Phase III is coming April 24

The IU Office of Research Compliance has released its latest update on the Kuali Coeus IRB implementation process. 

Phase III of the Kuali Coeus IRB implementation involves two main components: an enhanced exemption process as well as improvements to the system's overall functionality.

Kuali Coeus IRB is an open source system being deployed at IU through a series of phases, each designed to enhance and simplify the submission, approval, and management of research studies through an entirely web-based system. 

To learn more, see the IU Office of Research Compliance Newsletter.  

Health care film screening

The IU School of Public health at IUPUI will kick off National Public Health Week by screening "Escape Fire: The Fight to Rescue American Healthcare," a documentary about the U.S. healthcare system. The event takes place from 6 to 8 p.m. Wednesday, April 2, in the IUPUI Campus Center Theater.

Read more News to Use stories »